34 related articles for article (PubMed ID: 8379436)
1. Carcinogen-modified dendritic cells induce immunosuppression by incomplete T-cell activation resulting from impaired antigen uptake and reduced CD86 expression.
Woods GM; Doherty KV; Malley RC; Rist MJ; Muller HK
Immunology; 2000 Jan; 99(1):16-22. PubMed ID: 10651936
[TBL] [Abstract][Full Text] [Related]
2. Chemical carcinogens and antigens induce immune suppression via Langerhans' cell depletion.
Woods GM; Qu M; Ragg SJ; Muller HK
Immunology; 1996 May; 88(1):134-9. PubMed ID: 8707340
[TBL] [Abstract][Full Text] [Related]
3. The effect of cryo-treatment on epidermal Langerhans cells and immune function in mice.
Horio T; Miyauchi H; Kim YK; Asada Y
Arch Dermatol Res; 1994; 286(1):69-71. PubMed ID: 8141615
[No Abstract] [Full Text] [Related]
4. Langerhans cell migration patterns from sheep skin following topical application of carcinogens.
Ragg SJ; Dandie GW; Woods GM; O'Connell PJ; Muller HK
Int J Exp Pathol; 1994 Feb; 75(1):23-8. PubMed ID: 8142271
[TBL] [Abstract][Full Text] [Related]
5. Effect of tumor-promoting agents on density and morphometric parameters of mouse epidermal Langerhans and Thy-1+ cells.
Baxter CS; Andringa A; Chalfin K; Miller ML
Carcinogenesis; 1991 Jun; 12(6):1017-21. PubMed ID: 1675159
[TBL] [Abstract][Full Text] [Related]
6. Migration of interleukin-6 producing Langerhans cells to draining lymph nodes following skin sensitization.
Cumberbatch M; Hope JC; Dearman RJ; Hopkins SJ; Kimber I
Adv Exp Med Biol; 1995; 378():531-3. PubMed ID: 8526135
[No Abstract] [Full Text] [Related]
7. Depletion of Langerhans cells following carcinogen treatment is partly due to antigenicity.
Woods GM; Liew IH; Muller HK
Adv Exp Med Biol; 1993; 329():623-7. PubMed ID: 8379436
[No Abstract] [Full Text] [Related]
8. Antigen presentation in the skin: modulation by u.v. radiation and chemical carcinogens.
Muller HK; Bucana C; Kripke ML
Semin Immunol; 1992 Aug; 4(4):205-15. PubMed ID: 1391795
[TBL] [Abstract][Full Text] [Related]
9. Studies on Langerhans cell phenotype in human afferent skin lymph from allergic contact dermatitis.
Brand CU; Hunziker T; Gerber HA; Schaffner T; Limat A; Braathen LR
Adv Exp Med Biol; 1995; 378():523-5. PubMed ID: 8526132
[No Abstract] [Full Text] [Related]
10. Allergic contact dermatitis and Langerhans cells: comments on recent developments.
Baer RL
Cutis; 1993 Nov; 52(5):270-2. PubMed ID: 8299387
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
